5-(Trifluoromethyl)-N-(4-trifluoromethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

ID: ALA1784712

Chembl Id: CHEMBL1784712

PubChem CID: 51347393

Max Phase: Preclinical

Molecular Formula: C13H7F6N5

Molecular Weight: 347.22

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1ccc(Nc2cc(C(F)(F)F)nc3ncnn23)cc1

Standard InChI:  InChI=1S/C13H7F6N5/c14-12(15,16)7-1-3-8(4-2-7)22-10-5-9(13(17,18)19)23-11-20-6-21-24(10)11/h1-6,22H

Standard InChI Key:  QAWZBLSZJFEDEM-UHFFFAOYSA-N

Associated Targets(Human)

DHODH Tclin Dihydroorotate dehydrogenase (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

dhod Dihydroorotate dehydrogenase (710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydroorotate dehydrogenase (quinone), mitochondrial (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.22Molecular Weight (Monoisotopic): 347.0606AlogP: 3.91#Rotatable Bonds: 2
Polar Surface Area: 55.11Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.88CX LogD: 3.88
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.71Np Likeness Score: -2.02

References

1. Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, Floyd DM, Matthews D, Buckner FS, Charman SA, Phillips MA, Rathod PK..  (2011)  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.,  54  (11): [PMID:21517059] [10.1021/jm200265b]
2.  (2016)  Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase,